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Recessive mutations in RTTN, encoding the protein rotatin, were originally identiﬁed as cause of polymicrogyria, a cortical
malformation. With time, a wide variety of other brain malformations has been ascribed to RTTN mutations, including primary
microcephaly. Rotatin is a centrosomal protein possibly involved in centriolar elongation and ciliogenesis. However, the function of
rotatin in brain development is largely unknown and the molecular disease mechanism underlying cortical malformations has not
yet been elucidated. We performed both clinical and cell biological studies, aimed at clarifying rotatin function and pathogenesis.
Review of the 23 published and ﬁve unpublished clinical cases and genomic mutations, including the effect of novel deep intronic
pathogenic mutations on RTTN transcripts, allowed us to extrapolate the core phenotype, consisting of intellectual disability, short
stature, microcephaly, lissencephaly, periventricular heterotopia, polymicrogyria and other malformations. We show that the
severity of the phenotype is related to residual function of the protein, not only the level of mRNA expression. Skin ﬁbroblasts
from eight affected individuals were studied by high resolution immunomicroscopy and ﬂow cytometry, in parallel with in vitro
expression of RTTN in HEK293T cells. We demonstrate that rotatin regulates different phases of the cell cycle and is mislocalized
in affected individuals. Mutant cells showed consistent and severe mitotic failure with centrosome ampliﬁcation and multipolar
spindle formation, leading to aneuploidy and apoptosis, which could relate to depletion of neuronal progenitors often observed in
microcephaly. We conﬁrmed the role of rotatin in functional and structural maintenance of primary cilia and determined that the
protein localized not only to the basal body, but also to the axoneme, proving the functional interconnectivity between ciliogenesis
and cell cycle progression. Proteomics analysis of both native and exogenous rotatin uncovered that rotatin interacts with the
neuronal (non-muscle) myosin heavy chain subunits, motors of nucleokinesis during neuronal migration, and in human induced
pluripotent stem cell-derived bipolar mature neurons rotatin localizes at the centrosome in the leading edge. This illustrates the role
of rotatin in neuronal migration. These different functions of rotatin explain why RTTN mutations can lead to heterogeneous
cerebral malformations, both related to proliferation and migration defects.
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Introduction
The in utero development of the human cerebral cortex,
starting at 8 weeks of gestation, is a complex process de-
pending on different developmental steps including neuro-
genesis, neuronal migration, post-migrational organization
and connectivity (Barkovich et al., 2012; Guerrini and
Dobyns, 2014). Interruption of any of these pathways
may result in a malformation of cortical development, clas-
sically divided into disorders of neuronal proliferation (e.g.
microcephaly or megalencephaly), neuronal migration (e.g.
lissencephaly and neuronal heterotopia) and cortical organ-
ization (e.g. polymicrogyria). Autosomal recessive primary
microcephaly (MCPH) is a cortical malformation character-
ized by a reduced brain size at birth with an occipitofrontal
circumference of three standard deviations (SD) below the
age- and sex-matched norm (Barkovich et al., 2012;
Faheem et al., 2015). Multiple genes involved in pathways
of mitotic spindle formation, centrosome and centriole du-
plication, DNA replication, repair and damage response
have been linked to MCPH (Faheem et al., 2015). Several
processes regulating neuronal migration are linked to micro-
tubule structure and function, including participation of
centrosomes (the microtubule organizing centre) and primary
cilia (microtubule-based sensory organelles) (Guemez-
Gamboa et al., 2014; Guo et al., 2015; Romero et al.,
2018). In contrast, the mechanisms leading to cortical or-
ganization are heterogeneous and disorganization, as seen in
polymicrogyria, has for example been associated with vari-
ants of tubulin genes, such as TUBA1A (OMIM#602529),
TUBB2B (OMIM#612850), TUBB3 (OMIM#602661) and
TUBB (OMIM#191130) (Bahi-Buisson and Cavallin, 2016;
Romero et al., 2018).
Genetic alterations in rotatin, encoded by the RTTN
(OMIM #610436) gene, were originally linked to autosomal
recessive polymicrogyria in two families, but were later also
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associated with primary microcephaly and primordial dwarf-
ism in additional families (Kheradmand Kia et al., 2012;
Shamseldin et al., 2015; Grandone et al., 2016; Rump
et al., 2016; Vora et al., 2017; Cavallin et al., 2018;
Chartier et al., 2018; Stouffs et al., 2018; Wambach et al.,
2018). Studies in human ﬁbroblasts allocated rotatin to the
basal body of the primary cilium, suggesting involvement of
the protein in primary ciliogenesis and sonic hedgehog
(SHH) signalling (Kheradmand Kia et al., 2012; Wambach
et al., 2018). Further studies in the human cancer cell lines
HeLa, KE37 and U2OS showed that the protein also loca-
lized to the centrosome in interphase and mitosis (Stevens
et al., 2009; Kheradmand Kia et al., 2012; Chen et al.,
2017). Rttn/ knockout mouse embryos fail to undergo
axial rotation, neural tube closure, left-right speciﬁcation,
heart looping and are not viable (Faisst et al., 2002;
Chatterjee et al., 2007). Stevens et al. (2009) studied the
involvement of the Drosophila melanogaster RTTN homo-
logue Ana3 in centriole duplication, since Ana3 depletion led
to increased anastral spindles. Ana3 shows centrosomal lo-
calization distinct from centriole duplication mediator homo-
logues for human polo-like kinase 4 (PLK4), SAS-6, CPAP,
and STIL. Interestingly, many of these centriole duplication
proteins have been previously linked to microcephaly.
The centrosome is a conserved eukaryotic organelle con-
sisting of a pair of centrioles, an older mother and younger
daughter procentriole, embedded in a pericentriolar matrix
(Bettencourt-Dias et al., 2011). Each centriole is composed
of nine microtubule triplets, doublets or singlets (Stevens
et al., 2010). During G0 interphase, the centrosome mi-
grates to the cell cortex where the mother centriole forms
the basal body, nucleating the axoneme of the primary
cilium (Stevens et al., 2010; Bettencourt-Dias et al.,
2011). Preceeding cell division, in G1 or S phase, centro-
some duplication takes place. A new procentriole is
nucleated perpendicularly to each pre-existing centriole,
and will elongate in S and G2 phases (Marthiens and
Basto, 2014). During mitosis or M-phase, these two centro-
somes form the spindle poles and direct the formation of
bipolar mitotic spindles. The correct number of centro-
somes during mitosis is essential for accurate chromosome
segregation into daughter cells.
Ana3 mutant embryonic neuroblasts display an increase in
the mean number of centrosomes per cell (centrosome amp-
liﬁcation) (Stevens et al., 2009). However, this is in contrast
with loss of centriole duplication factors PLK4, SAS-6 and
CPAP, leading to a decrease in the mean number of centro-
somes per cell in D. melanogaster and human cells (Stevens
et al., 2009; Gambarotto and Basto, 2016).
Centrosome ampliﬁcation during mitosis can lead to aneu-
ploidy with multipolar spindle assembly, asymmetric cell div-
ision or multiple cilia formation (Bettencourt-Dias et al., 2011).
In human, variants in genes MCPH1 (microcephalin 1,
OMIM#607117), CDK5RAP2 (MCPH3, OMIM#608201),
CDK6 (OMIM#603368), STIL (OMIM#181590) and
CEP135 (OMIM#611423) lead to centrosome ampliﬁcation
and are associated with microcephaly (Barrera et al., 2010;
Marthiens et al., 2013; Arquint and Nigg, 2014; Marthiens
and Basto, 2014; Gambarotto and Basto, 2016). CEP135 and
STIL proteins have been proposed to interact with rotatin
during the early phase of centriole elongation (Gupta et al.,
2015; Chen et al., 2017).
Although evidence has been provided that rotatin is a
centrosome-related protein, its role during the main events
related to centriolar function, i.e. mitosis and ciliogenesis, is
largely elusive. The fact that human RTTN variants have
been described with heterogeneous cerebral malformations
and clinical course, induced us to systematically review the
clinical presentation and explore the protein function in
mutant cells from several unrelated affected individuals.
Materials and methods
Cases
The study was approved by the local IRB of the Erasmus MC
University Medical Center Rotterdam (protocol METC-
2012387). Clinical data and material from affected individuals
were recruited through collaboration within the European
Network on Brain Malformations (Neuro-MIG, COST
Action CA16118; www.neuro-mig.org). Written informed con-
sent was obtained from all parents/caretakers. Fibroblasts from
affected individuals were obtained from skin biopsies previ-
ously sampled for routine diagnostics. Further experimental
procedures are provided in the Supplementary material.
Data availability
WES/WGS data are deposited internally at the Erasmus MC
and in each medical institute referring the patients, in respect
to the privacy of the families.
The mass spectrometry proteomics data have been deposited
in the ProteomeXchange Consortium (Deutsch et al., 2017) via
the PRIDE (Vizcaı´no et al., 2016) partner repository with the
dataset identiﬁer PXD012415.
Results
Genetic alterations of RTTN in novel
families
Germline variants in RTTN have been reported in 13
families, with a total of 23 affected individuals
(Kheradmand Kia et al., 2012; Shamseldin et al., 2015;
Grandone et al., 2016; Rump et al., 2016; Vora et al.,
2017; Cavallin et al., 2018; Chartier et al., 2018; Stouffs
et al., 2018; Wambach et al., 2018). Here we report three
additional families, including ﬁve affected individuals, and
two novel recessive alterations in RTTN. Clinical reports of
novel cases are summarized in the Supplementary material
and Supplementary Table 7, and respective brain MRI
images can be found in Fig. 1. We also included one
family with two affected siblings, in which an RTTN
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Figure 1 Brain MRI images from patients with biallelic RTTN mutations (A–P) and graphical overview of all RTTN mutations
(Q). (A–D) Proband of Family A (P1) MRI at age 9 months. (A and B) T2-weighted axial images showing diffuse simplified gyri and abnormal
cortex with a suspected subcortical ribbon of neurons separated by a cell sparse zone (arrows), a modest anterior4 posterior gradient,
moderately enlarged occipital horns of lateral ventricles, normal basal ganglia. (C and D) Midsagittal and parasagittal T1-weighted images showing
870 | BRAIN 2019: 142; 867–884 L. V. Vandervore et al.
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mutation was described but for whom no clinical details
were reported (Rump et al., 2016).
In Family A, the compound heterozygous variants found
in exon 20 and 31 of RTTN (c.[2594A4G];[4186del],
p.[His865Arg];[Glu1397Lysfs*7], NM_173630.3) were dis-
covered by exome sequencing during a microcephaly cohort
screening and were reported previously (Rump et al.,
2016).
In Family B (Supplementary Table 7), homozygosity map-
ping (using Affymetrix 6.0 SNP arrays) identiﬁed regions of
homozygosity in ﬁve chromosomes, comprising 309 genes in
two affected sisters, which are not shared by their healthy
brother. Whole genome sequencing was negative for coding
homozygous pathogenic variants in regions of homozygos-
ity. However, a candidate gene approach led by the pheno-
type identiﬁed a homozygous c.[2309þ1093G4A] splice
variant in intron 17 of RTTN, creating a new splice acceptor
site at c.2309þ1095. The variant does not appear in ExAC,
dbSNP, ESP, GoNL and gnomAD databases (coverage for
each analysis is shown in Supplementary Table 3).
In Family H, a homozygous variant c.[2953A4G] was
found by whole exome sequencing, affecting the penulti-
mate nucleotide in exon 23 of RTTN, identical to that
reported in Families C and D (Grandone et al., 2016;
Cavallin et al., 2018). Aberrant splicing was reported in
Families C and D and veriﬁed in this study. The arginine
at position 985 is highly conserved among different ortho-
logues, although not located at an armadillo type fold
domain of rotatin. All three families are Moroccan and
consanguineous. This variant does not appear in the
ExAC, dbSNP, ESP, GoNL and gnomAD databases.
In Family I, a compound heterozygous change was found
by exome sequencing c.[3705C4A];[4748–19T4A]. The
ﬁrst paternal variant leads to a premature stop
p.[Tyr1235*] in exon 28. The second maternal variant in
intron 35 is predicted to lead to a novel splice acceptor site
at position c.4748–17, which is predicted to lead to an
insertion of 17 bp and a premature stop. Both variants
did not appear in other genome databases (ExAC,
dbSNP, ESP, GoNL, gnomAD).
Recessive variants in RTTN lead to a
variable phenotypic spectrum
Following our report in 2012 of RTTN mutations in indi-
viduals with intellectual disability and cerebral polymicro-
gyria, additional subjects have been described with a
different clinical presentation, including other brain malfor-
mations (primary microcephaly), growth defects and con-
genital anomalies (Kheradmand Kia et al., 2012;
Shamseldin et al., 2015; Grandone et al., 2016; Rump
et al., 2016; Vora et al., 2017; Cavallin et al., 2018;
Chartier et al., 2018; Stouffs et al., 2018; Wambach
et al., 2018). The phenotypic spectrum that emerges after
reviewing all clinical reports with bi-allelic RTTN variants
has been summarized in Table 1 and shows that the most
common, although not obligate, features are severe intellec-
tual disability, lack of speech and primary microcephaly.
Primordial dwarﬁsm (deﬁned as birth weight and length
52.5 SD for gestational age and gender) is common in
microcephalic newborns. Cortical malformations have
been observed in all individuals studied with brain imaging
or at post-mortem. The spectrum is broad, ranging from
polymicrogyria-like dysgyric cortex with borderline small
head in milder cases, to severe congenital microcephaly
with large interhemispheric cysts and CSF ﬁlling most of
the skull, up to disruptive appearance of schizencephaly.
The cortical malformation is often predominant in frontal
regions, suggesting elective underdevelopment of frontal
lobes (Fig. 1) (Cavallin et al., 2018). Normal pressure
hydrocephalus, prominent in Rttn/ knockout mice, is
also present in several individuals (Shamseldin et al.,
2015) (Family I, Supplementary Table 2). The clinical se-
verity correlates with the extension of the migration dis-
order and with the extent of microcephaly, individuals
with pachygyria and commissural dysgenesis being more
severely affected than the ones with microcephaly and sim-
pliﬁed gyri or polymicrogyric cortex and borderline micro-
cephaly. As in mice, variable congenital anomalies of
internal organs occur, particularly in the urogenital
system, suggesting prominent involvement of the endo-
Figure 1 Continued
hypoplastic corpus callosum, pachygyric cortex and normal cerebellum. (E–H) Affected sister of P1 Family A, MRI at age 8 years. (E and F)
T2-axial images showing diffuse pachygyria with anterior4 posterior gradient, enlarged occipital horns of lateral ventricles, normal basal ganglia,
small intraparenchymal cyst in the left occipital horn. (G) Sagittal T1 image showing thin hypoplastic corpus callosum. (H) Coronal T2 image
showing pachygyria of the temporo-parietal cortex, thin subcortical band of neurons parallel to the ventricular surface (arrow) and an apparent
cell sparse area under the cortex (arrow head). (I and J) Proband of Family C (P3). MRI at 2 years, (I) axial T2-weighted image showing a grey
matter ribbon apparently bridging across the frontal hemispheres and seemingly fused basal ganglia (red arrow), nodular heterotopia (thin arrows)
and temporo-parietal polymicrogyria (thick arrow). (J) Sagittal T1-weighted image showing hypoplastic rostrum and splenium of corpus callosum
with increased interhemispheric space. (K and L) Proband of Family F (P6) MRI at the age of 1 year. IR-T1 and T2-weighted images showing diffuse
but asymmetric cortical dysgyria, with frontal predominance and enlarged ventricles, respectively. (M and N) Proband of Family H MRI at birth.
(M) Sagittal T1 showing severe enlarged ventricle and cortical dysgyria. (N) Coronal T2 image showing ventriculomegaly and thin hypointense
cortical layer, possibly microgyric. (O) T2-weighted images MRI at the 27th week of gestation of proband 1 from Family I, showing large
intracranial cyst and underdeveloped cortex. (P) T2-weighted image MRI of proband 2, Family I, at 24th week of gestation, showing large
interhemispheric cyst and underdeveloped cortex. (Q) Schematic overview of all reported and novel RTTN mutations with specified protein
domains.
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Table 1 Summary of RTTN mutation phenotypes in all published and novel cases reported herein
Disease manifestation Number of individuals with RTTN alteration (n = 28) Percentage of all
assessed individuals
Growth parameters and survival
Primary microcephaly (OFC5 2.5 SD at birth) 17/21 81%
7 not knowna: (Kheradmand Kia et al., 2012; Shamseldin et al., 2015; Wambach et al.,
2018), Family B
Primordial dwarfism (length 52.5 SD at birth) 7/20 35%
8 not knowna: (Shamseldin et al., 2015; Chartier et al., 2018), Family B
Pre-natal demise 5/28 terminated pregnancies 18%
Family I and Chartier et al., 2018
Postnatal early death 4/23 17%
2 months (Shamseldin et al., 2015), 17 days (Shamseldin et al., 2015), 4 months (Wambach
et al., 2018) and 12 years (Rump et al., 2016)
Postnatal microcephalya 7/23 30%
(Kheradmand Kia et al., 2012; Shamseldin et al., 2015; Wambach et al., 2018), Family B
Postnatal short staturea 10/23 43%
(Shamseldin et al., 2015; Rump et al., 2016; Stouffs et al., 2018; Wambach et al., 2018)
Clinical features (n = 23)b
Moderate/severe developmental delay, age 42 years 20/20 100%
No speech or few words. age 42 years 18/20 90%
Except (Kheradmand Kia et al., 2012; Rump et al., 2016)
Seizures 4/23 17%
(Kheradmand Kia et al., 2012; Wambach et al., 2018), Family H
Wheelchair-bound 1/20 (Family H) 5%
Independent walking (age) 8/20 (16 months–2.6 years) 40%
(Shamseldin et al., 2015; Grandone et al., 2016; Rump et al., 2016; Stouffs et al., 2018),
Family B
Congenital eye anomalies (micropthalmia, abnormal
orbitae, ankyloblepharon, optic hypoplasia)
2/23 9%
(Wambach et al., 2018); Family H
Congenital heart disease 3/23 13%
Tetralogy of Fallot (Rump et al., 2016), atrial septal defect (Grandone et al., 2016)
Kidney defect (agenesis, ectopy, pyelocaliectasis) 5/23 22%
(Kheradmand Kia et al., 2012; Shamseldin et al., 2015; Rump et al., 2016; Wambach et al.,
2018)
Gastrointestinal (duodenal atresia) 1/23 4%
(Shamseldin et al., 2015)
Urogenital system (cryptorchid-ism, micropenis,
double uterus)
9/23 39%
(Shamseldin et al., 2015; Grandone et al., 2016; Rump et al., 2016; Wambach et al., 2018),
Family B and Family H
Skin abnormality (congenital dermatitis) 4/23 17%
(Grandone et al., 2016; Rump et al., 2016; Stouffs et al., 2018)
Skeletal congenital anomalies
(kyphoscoliosis, hip dysplasia)
4/23 17%
(Rump et al., 2016; Stouffs et al., 2018), Family B
MRI (n = 23)c
Simplified gyration 10/23 43%
(Shamseldin et al., 2015; Chartier et al., 2018; Wambach et al., 2018) and Families H and I
Lissencephaly/pachygyria 11/23 48%
(Shamseldin et al., 2015; Grandone et al., 2016; Rump et al., 2016; Cavallin et al., 2018;
Stouffs et al., 2018) and Families H and I
Polymicrogyria/dysgyria NOS/schizencephaly 7/23 30%
(Kheradmand Kia et al., 2012; Shamseldin et al., 2015; Cavallin et al., 2018; Stouffs et al.,
2018) and Family I
Nodular heterotopia 6/23 26%
(Shamseldin et al., 2015; Grandone et al., 2016; Cavallin et al., 2018; Chartier et al., 2018)
and Family H
Subcortical band heterotopia 1/23 4%
(Rump et al., 2016)
Suspected holoprosencephaly 2/23 9%
(Shamseldin et al., 2015; Cavallin et al., 2018)
Other midline developmental defect (aplasia of
olfactory bulbs, hypoplastic CC)
15/23 65%
(Kheradmand Kia et al., 2012; Shamseldin et al., 2015; Grandone et al., 2016; Rump et al.,
2016; Vora et al., 2017; Stouffs et al., 2018) and Families H and I
Interhemispheric posterior arach-noid cyst 4/23 17%
(Grandone et al., 2016; Vora et al., 2017) and Family I
(Ponto)cerebellar hypoplasia 7/23 30%
(Kheradmand Kia et al., 2012; Shamseldin et al., 2015; Grandone et al., 2016; Vora et al.,
2017; Wambach et al., 2018)
aIn these individuals no OFC or length at birth was recorded.
bNo additional features mentioned in five terminated pregnancies and in features where was specified (42 years of age), n = 20 since three patients died in infancy.
cPermission denied from Family B, Family F oldest sister 5, and Family 1 V:3 and V:41.
CC = corpus callosum; OFC = occipitofrontal circumference; NOS = not otherwise specified.
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crine/pituitary system. Eye globes, orbits and eyelid
abnormalities are relatively frequent in severe cases (9%
of total), which together with the underdevelopment of
the frontal lobes, the frequent occurrence of midline defects
(65%) and signs of pituitary failure (growth and endocrine
anomalies), indicates, besides dorsal, also maldevelopment
of ventral telencephalon.
RTTN mRNA expression and rotatin
protein in cells from affected
individuals
We were able to obtain and investigate cultured skin ﬁbro-
blasts from eight affected individuals, here indicated as P1
[proband 1 from Family A (Rump et al., 2016)], P2
(proband 1 from Family B), P3 [proband 1 from Family
C (Cavallin et al., 2018)], P4 [Family D (Grandone et al.,
2016)], P5 [Family E (Kheradmand Kia et al., 2012)], P6
[Family F (Kheradmand Kia et al., 2012)], and P7 and P8
[probands 1 and 2 from Family G (Stouffs et al., 2018)],
belonging to seven families. Quantitative reverse transcrip-
tion-polymerase chain reaction (RT-qPCR) (Fig. 2A) or RT-
PCR (Supplementary Fig. 1) of RTTN mRNA in these
ﬁbroblasts was carried out.
With RT-qPCR, residual RTTN transcript could be de-
tected in cells from all affected individuals. P1–P3 showed a
signiﬁcant decrease in RTTN mRNA expression (Fig. 2A).
P1 presents a compound heterozygote variant
c.[2594A4G];[4186del] leading to p.His865Arg and
p.Glu1397Lysfs*7 and shows the lowest expression of
RTTN mRNA. Sanger sequencing of RTTN mRNA in
Figure 2 Expression of RTTN and localization of rotatin protein in human fibroblasts of affected individuals compared to
healthy controls. (A) Quantitative PCR of RTTN mRNA expression shows that RTTN is significantly lower expressed in P1–P3. CLK2 and
RNF111 were used as reference genes. Data are represented as the mean  standard error of mean (SEM). Statistical two-tailed unpaired t-tests
were performed with Welch’s correction (***P = 0.0004, **P = 0.0017 for P2 and **P = 0.0055 for P3). (B) Fluorescent confocal imaging of human
fibroblast metaphases from a representative control and P1. Antibodies were used for anti-human acetylated tubulin (red) to stain mitotic spindle
and anti-human SASY to visualize rotatin (green), with DAPI for DNA (blue). Scale bars = 1 mm.
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this individual showed a low expression of the c.4186del
allele, resulting in a frameshift in exon 31 and a premature
stop codon, suggesting that this transcript is subjected to
nonsense-mediated mRNA decay. The other allele was ex-
pressed containing the pathogenic c.2594A4G missense
variant (Supplementary Fig. 1A).
RT-PCR and Sanger sequencing of RTTN mRNA in the
exons surrounding the c.[2309þ1093G4A] splice alter-
ation showed that the reduced RTTN mRNA expression
of P2 consisted of both normal (wild-type) and altered tran-
script, containing an extra exon between exons 17 and 18
(p.[Ser770_Val771ins10*]) (Supplementary Fig. 1B). This
exon was generated using the newly formed acceptor
splice site at position c.2309þ1095 and an existing wild-
type donor splice site at position c.2309þ1180. Insertion of
this extra exon leads to a premature stop codon 10 amino
acids after the new acceptor site. Most likely this results in
nonsense-mediated mRNA decay and suggests that the
transcript visualized in Fig. 2 escapes this alternative spli-
cing and represents wild-type RTTN.
The RTTN sequence of P3 and P4 ﬁbroblasts shares the
same c.[2953A4G] splice variant. With RT-PCR, three
transcripts were found, one wild-type, one lacking exon
23 (p.[Trp962_Arg985del]; most abundant) and one lack-
ing both exons 22 and 23 (p.[Val930_Arg985del])
(Supplementary Fig. 1C). Although both families share
the same variant and transcripts, mRNA levels and pheno-
type severity are variable (Grandone et al., 2016; Cavallin
et al., 2018).
The other affected individuals, P5–P8, did not show a
signiﬁcantly decreased RTTN mRNA expression in their
ﬁbroblasts.
To determine rotatin protein level, speciﬁcity of a puriﬁed
custom-made polyclonal rabbit anti-human rotatin antibody
(so-called SASY, see Supplementary material) was tested on
western blot after immunoprecipitation of overexpressed ex-
ogenous (Myc-tagged) rotatin in HEK293T cells, transfected
with a vector containing full-length RTTN sequence
(Supplementary material and Supplementary Fig. 2A) and
tested with immunocytochemistry in HEK293T cells express-
ing exogenous rotatin (Supplementary Fig. 2B) (Kheradmand
Kia et al., 2012). Endogenous rotatin protein level was
below detection limit on western blots in human control
ﬁbroblasts. However, the SASY antibody was sufﬁcient to
identify rotatin by immunocytochemistry in human ﬁbro-
blasts, in both controls and mutants, indicating that none
of the human variants abolish RTTN expression completely
(Fig. 2B and Supplementary Fig. 2C). In control ﬁbroblasts,
as previously reported for HeLa, KE37 and U2OS cells
(Stevens et al., 2009; Kheradmand Kia et al., 2012; Chen
et al., 2017), rotatin concentrated at the centrosomes during
mitosis (Fig. 2B and Supplementary Fig. 2C). Interestingly, in
mitoses examined in RTTN mutant ﬁbroblasts, rotatin was
not concentrated at the centrosomes but showed a weak and
diffuse granular cytoplasmic staining, indicating that all tested
variants lead to mislocalization of the protein (Supplementary
Fig. 2C). This prompted us to question the effect of RTTN
mutations on centrosome function and mitosis.
Rotatin in mitosis
RTTN mutant fibroblasts exhibit centrosome
amplification
To study the effect of RTTN variants on centrosome function
and mitosis, we systematically followed all the phases of mi-
tosis in RTTN mutant cells using mitotic spindle marker
acetylated tubulin, centrosome marker gamma tubulin and
DNA marker DAPI. In cell lines from affected individuals,
we signiﬁcantly and consistently observed an increase of mi-
totic spindles with more than two centrosomes, starting from
the prophase, leading to multipolar spindles and abnormal
distribution of centrosomes during mitosis and cytokinesis.
Centrosome ampliﬁcation is shown in different phases of mi-
tosis in all the cell lines with RTTN mutation in this cohort
(Fig. 3A and Supplementary Fig. 3A–H) compared to healthy
controls (Supplementary Fig. 3I), with statistical signiﬁcance
(10–14% multipolar divisions versus 0–1% in 10 control cells
lines, Fig. 3B). When healthy human ﬁbroblasts were treated
with siRNA targeting RTTN mRNA, abnormal centrosome
ampliﬁcation was observed during all phases of cell division
in 7% of the mitotic cells (Fig. 3B and C), proving that the
observed multipolar spindle formation is a direct consequence
of RTTN inactivation.
Rotatin regulates G2/M cell cycle progression and
bipolar spindle formation
If a cell has more than two centrosomes during cell div-
ision, several pathways to repair bipolar spindle assembly
may be activated, leading to centrosome clustering or
centrosome inactivation (Marthiens et al., 2012). This re-
sults in prolongation of the cell cycle (Marthiens et al.,
2012). When repair mechanisms are inefﬁcient, centrosome
numerical abnormalities in mitosis can lead to apoptotic
cell death due to multipolar cell division creating aneu-
ploidy or due to kinetochore-merotelic attachment errors
creating chromosome instability (Marthiens et al., 2012).
During interphase, centrosome ampliﬁcation can lead to
multiple basal body and primary cilia formation, as
observed in Cdk5rap2/MCPH3 mutant mouse embryonic
ﬁbroblasts (Barrera et al., 2010; Marthiens et al., 2012).
To further determine the consequences of centrosome amp-
liﬁcation in RTTN mutants, Hoechst 33342-mediated ﬂow
cytometric cell cycle analysis was performed in affected
ﬁbroblasts (Fig. 4A–F). This revealed a decrease in G1-
phase and a G2/M cell cycle arrest in RTTN mutated
cells (Fig. 4A and C). Histograms of RTTN mutant cell
cycle also showed DNA fragmentation in sub-G1 phase,
suggesting increased apoptotic cell death, compared to con-
trols (Fig. 4D). Increase in apoptosis, often regulated by
activation of p53, is a known consequence of the observed
centrosome ampliﬁcation since this can result in aneuploidy
(Aylon and Oren, 2011; Marthiens et al., 2013). Indeed,
we observed a signiﬁcant increase in aneuploid cells in P1
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ﬁbroblasts (Fig. 4E). Moreover, complete knockout of
RTTN in RPE1 cells was only viable in a Tp53/ back-
ground, supporting this hypothesis (Chen et al., 2017).
Though Tp53 messenger RNA and protein level were not
signiﬁcantly altered in the RTTN mutant ﬁbroblasts
(Supplementary Fig. 4A and B), differential post-
translational activation of p53 could cause the increased
apoptosis.
RTTN depletion not only affects the cell cycle phase dis-
tribution, ploidy and apoptosis, but also inﬂuences bipolar
cell division and cell cycle duration. Real-time imaging of
the ﬁbroblasts’ mitoses in healthy control cells and P1
Figure 3 RTTN mutant fibroblasts exhibit centrosome amplification during all phases of the mitosis. (A) Fluorescent confocal
imaging showing representative mitotic cells in all phases of cell division with more than two centrosomes in human fibroblast cells with RTTN
mutation, compared to normal bipolar spindle formation with two centrosomes in healthy control cell lines. Antibodies used were mouse
monoclonal anti-human acetylated tubulin (red), rabbit polyclonal anti-human gamma tubulin (green) and DAPI (blue). (B) Double-blind quan-
titative analysis of mitotic cells with more than two centrosomes in human fibroblast cells of all RTTN cases compared to healthy controls. Data
are represented as the mean  SEM. Statistical two-tailed unpaired t-tests were performed (***P5 0.0001). (C) Fluorescent confocal imaging of
mitotic cells with more than two centrosomes in human fibroblast cells after 48 h siRTTN treatment indicating centrosome amplification.
Antibodies used were mouse monoclonal anti-human acetylated tubulin (red), rabbit polyclonal anti-human gamma tubulin (green) and DAPI
(blue).
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Figure 4 Rotatin in mitosis regulates G2/M cell cycle progression and bipolar spindle formation. (A–F) Flow cytometric cell cycle
analysis in human fibroblasts of three healthy controls and P1 after staining with Hoechst 33342, showing percentage of fibroblasts (A) in G1 cell
phase, (B) in S phase, (C) in G2/M phase, (D) in apoptotic sub-G1, (E) with aneuploidy (44 N) (adapted y-axis) and (F) the accompanying flow
cytometry histograms of the cell lines. Analysis was performed with FlowJo 7.6.5 and statistical two-tailed unpaired t-tests were performed
(***P5 0.0001). Data are represented as the mean  SEM. (G–I) Time-lapse brightfield microscopic imaging of control and P1 human fibroblasts,
showing (G) bipolar divisions in healthy control fibroblasts, (H) a tripolar division in P1, and, (I) an overall increase in the duration of mitosis for
multipolar divisions (n = 2) compared to bipolar divisions (n = 10) (unpaired t-tests were performed, P5 0.0001). Data are represented as the
mean  SEM.
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revealed that RTTN mutation led to tripolar/multipolar cell
divisions (Fig. 4H). All control ﬁbroblasts divided in a bi-
polar manner. When comparing the duration of mitosis
between both cell lines by time-lapse microscopy, multi-
polar divisions showed a highly signiﬁcant increase in dur-
ation of each cell cycle (80min in control versus 120min in
P1 cells) (Fig. 4I). Prolonged mitosis is often observed with
centrosome ampliﬁcation, since the spindle assembly check-
point network will only stimulate the cell to progress to
mitosis when accurate chromosome segregation can be
guaranteed (Basto et al., 2008; Marthiens et al., 2012).
This result correlates with the ﬂow cytometry data showing
a G2/M phase arrest. If the cell has more than two centro-
somes, this requires more kinetochore-microtubule inter-
actions to stabilize the cell and favours centrosome
clustering (Marthiens et al., 2012). This prolongation
does not always lead to correct division of the cell, and
still can result in multipolar divisions (Marthiens et al.,
2012), as was shown in our experiment (Fig. 4H).
Rotatin in ciliogenesis and SHH
signalling
Cell cycle defects in neuronal progenitors can lead to
microcephaly. Individuals with RTTN mutations, however,
not only present with primary microcephaly, but also dis-
play a broader cortical phenotype because of impaired
neuronal migration and post-migrational organization. We
have previously shown that cells with pathogenic RTTN
variants build up short cilia (53 mm) (Kheradmand Kia
et al., 2012). We therefore expanded the study on the
effect of RTTN alterations on primary cilia structure and
function in patient-derived ﬁbroblasts and performed de-
tailed analyses of interactors with full-length rotatin
protein.
We previously localized rotatin to the basal body of the
primary cilium, while ﬁbroblasts transfected with siRTTN
displayed shorter primary cilia axonemes (Kheradmand Kia
et al., 2012). Here, we conﬁrm these results in ﬁbroblasts
from additional affected individuals of this cohort (Fig. 5A–
C). After serum starvation, we localized rotatin to the basal
body but also to the axoneme of the primary cilium in
control and RTTN mutant ﬁbroblasts, suggesting dynamic
localization of rotatin (Fig. 5A). Six of the eight RTTN
mutants displayed a percentage of cilia below normal
(Fig. 5C). Five of the cell lines (P2, P4, P6–P8) also
showed a signiﬁcant amount of short cilia (P5 0.05,
length axoneme 53 mm), conﬁrming our previous observa-
tion (Fig. 5B) (Kheradmand Kia et al., 2012).
SHH signalling is one of the major pathways regulated at
the primary cilium and Rttn/ mice exhibit clinical fea-
tures reminiscent of aberrant SHH function (axial rotation
defects, neural tube and left-right patterning defects) (Faisst
et al., 2002; Kheradmand Kia et al., 2012). Mutations in
microcephaly-associated genes CDK5RAP2, CEP152,
CPAP, KATNB1 and mouse Stil result in defective SHH
signalling, impact cilium assembly/function, indicating that
primary cilia are important for neural progenitor mainten-
ance in the neocortex (Megraw et al., 2011; Patwardhan
et al., 2018).
We tested SHH signalling by measuring the increase in
Gli1 mRNA expression after stimulation of the SHH path-
way with purmorphamine, a SHH signalling agonist, in
cultured ﬁbroblasts from our P1 to P8 individuals and
healthy controls (Supplementary Fig. 5). We observed a
reproducible reduced stimulation of Gli1 expression in
some but not all RTTN mutant cells (P1–P3), compared
to control cells. These results indicate that RTTN muta-
tions can impair both structural and functional integrity
of primary cilia.
Rotatin interacting proteins
Mass spectrometry was performed on immunoprecipitation
assays on both exogenous full-length and endogenous rota-
tin to detect interacting proteins. A full-length rotatin ex-
pressing vector was transfected in HEK293T cells,
presenting mitoses (medium containing foetal calf serum,
no stimulation of ciliogenesis) (Supplementary material). In
a ﬁrst duplicate experiment, in the top list of signiﬁcant
interactors with exogenous rotatin, appears the non-muscle
cellular heavy chain myosin complex (NMHC), consisting of
three isoforms myosin-9 (MYH9), myosin-10 (MYH10) and
myosin-14 (MYH14) (Samples 1 and 2 in Supplementary
Table 4 and Experiment 1 in Supplementary Table 5), mito-
chondrial (respiratory chain) proteins and proteins with ex-
quisite nuclear localization. Interestingly, the neuronal
isoform myosin 10 presented with the highest enrichment
ratio (Experiment 1 in Supplementary Table 5). In repeat
experiments, NMHC subunits were again detected, albeit
not on top of the list, after pull down of both endogenous
and exogenous (Myc-tagged) rotatin (Supplementary Tables
5 and 6). Background levels of MYH10 were determined
based on immunoprecipitation of empty Myc-tagged beads
with and without transfection of empty vector. Although
some immunoprecipitated rotatin samples showed weaker
interaction with MYH10, the number of unique peptides
was still higher than in these negative controls. Moreover,
liquid chromatography/mass spectrometry after immunopre-
cipitation of endogenous rotatin showed high and consistent
interaction with unconventional myosin-18A (MYO18A),
which is highly expressed in neurons and known to co-as-
semble with non-muscle cellular heavy chain myosins into
mixed bipolar ﬁlaments (Billington et al., 2015)
(Supplementary Table 6). Because MYH10 is the neuronal
isoform, speciﬁc binding of rotatin with MYH10 was recip-
rocally conﬁrmed on western blot after immunoprecipitation
of endogenous MYH10 in HEK293 cells transfected with
the RTTN-Myc vector (Supplementary Fig. 6). The inter-
action was conﬁrmed after mass spectrometry of pulled
down endogenous rotatin using SASY antibody and detec-
tion of MYH10 (Supplementary Table 6) (Juanes-Garcia
et al., 2015). In skin ﬁbroblasts, immunoprecipitation of
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Figure 5 Rotatin in ciliogenesis. (A) Fluorescent 3D-SIM microscopy showing rotatin localization (green) at the basal body and axoneme
during ciliogenesis 48 h after serum starvation of human control fibroblast cells and only at the axoneme in a representative RTTN mutant cell line.
Antibodies were used for anti-human acetylated tubulin (red) to stain the axoneme and anti-human SASY to visualize rotatin (green), with DAPI
for DNA (blue). Scale bars of the enlarged primary cilia represent 1 mm. (B) Primary cilium axoneme staining with anti-human acetylated tubulin
(red) and basal body staining with anti-human -tubulin (green) in human fibroblasts of one control human cell line, one representative RTTN
mutant P1 and one CEP290 mutant cell line, with a compound heterozygous variant c.[1501G4T];[4522C4T], p.[Glu501*];[Arg1508*], showing
shorter cilia in RTTN mutants and CEP290 ciliopathy control. (C) Percentage of normal and short (53 mm) cilia in all cell lines after initiation of
ciliogenesis through 48 h of serum starvation (0.5% foetal calf serum), showing significant lower number of normal cilia and increase of shorter cilia
in multiple individuals with RTTN mutation (statistical two-tailed unpaired t-tests, **P5 0.005 *P5 0.05). The normal range for ciliation (50–80%)
is shown by dashed red lines and was determined from 100 experiments using several different control fibroblast lines. As a positive ciliopathy
control we used the human CEP290 mutant cell line, showing 12% of normal cilia and 8% of short cilia with a total of 20% ciliated cells. Values
indicate average  SEM for separate duplicate or quadruplicate experiments.
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rotatin revealed co-precipitation of MYH10, conﬁrming this
interaction although no clear-cut difference could be appre-
ciated between controls and cells from affected individuals
(Supplementary Fig. 7). Among structural centrosomal pro-
teins, CETN2 (centrin 2) showed a signiﬁcant enrichment
ratio in experiments with exogenous rotatin (Experiments
1 and 2 in Supplementary Table 5). Mass spectrometry of
endogenous rotatin did show binding with other centroso-
mal/basal body proteins PCNT (pericentrin), BBS1 and BBS7
(Bardet-Biedl syndrome 1 and 7), CEP97 (Supplementary
Table 6), and consistent interaction with TUBB3 and
TUBB6 beta chain tubulin, which are microtubule associated
proteins necessary for cell division, neuronal migration and
TUBB3 mutations have been associated with cortical mal-
formations (Supplementary Table 6) (Bahi-Buisson and
Cavallin, 2016).
Rotatin in neuronal migration
Migration of bipolar neuronal progenitors along a radial
glial scaffold is essential for the proper lamination of the
cortex and is regulated by a two-step process. First, the
centrosome and Golgi apparatus are migrating from the
perinuclear zone into the leading edge of the migrating
neuron. Secondly, the forward nuclear movements are
orchestrated by the perinuclear microtubule cage, anchored
to the centrosome, and the actomyosin cytoskeleton (nu-
clear translocation or nucleokinesis) (Bellion et al., 2005).
Alterations in genes regulating these individual steps, are
known to lead to malformation of cortical development
e.g. LIS1, dynein and DCX. Human induced pluripotent
stem cell (iPSC)-derived mixed neuronal cultures containing
radial glial-like progenitors can recapitulate migrating bipo-
lar neurons and have been instrumental to show migration
defects in cells with LIS1 mutations (Bamba et al., 2017).
We studied the expression of rotatin in human iPSC-
derived neuronal cultures generated from healthy control
ﬁbroblasts according to Quadri et al. (2018). These cultures
contain mature differentiated neuronal lineages (MAP2-
and beta tubulin III-positive staining), mixed with mature
radial glial cells (GFAP- and vimentin-positive) (Fig. 6A, B
and Supplementary Fig. 8) and have been shown to contain
both dopaminergic and glutamatergic lineages (Reinhardt
et al., 2013; Quadri et al., 2018). Some of these cells
assume a bipolar structure typical of migrating neurons,
with a clearly recognizable leading edge, as deduced by
the position staining of the leading centrosome (-tubulin-
positive) (Fig. 6B). Rotatin localization was polarized with
-tubulin at the neuronal leading edge (Fig. 6B). MYH10
was also detected in the perikaryon, predominantly at the
leading edge of the migrating neurons, corresponding to its
previously established role in nuclear dynamics and co-
localizing with rotatin (Fig. 6A).
Discussion
Clinical phenotype
In this manuscript we reviewed the phenotypic characteris-
tics observed in all previously published and novel individ-
uals (n = 28) with RTTN mutations.
The emerging global phenotype is heterogeneous, and
conﬁrm the original description of two apparently separate
Figure 6 Rotatin localization in human iPSC-derived neurons. (A) Endogenous rotatin (green, rabbit anti-human RTTN SASY antibody)
localized at the leading edge of the neuron, together with MYH10 at the proximal end of the leading process (red, mouse monoclonal anti- human
non-muscle myosin IIB antibody). Neuronal marker major microtubule associated protein (MAP2) was stained in magenta to confirm neuronal
identity with guinea pig polyclonal anti-human MAP2. (B) Endogenous rotatin (green) co-localized with centrosome marker y-tubulin (red). Nuclei
are visualized with DAPI (blue).
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clinical entities: at the milder end of the spectrum a neuro-
developmental delay syndrome, near normal growth with a
polymicrogyria-like cortical malformation and, at the
severe end, a microcephalic primordial dwarﬁsm (MPD)
with different types of cortical malformation (Fig. 1 and
Table 1) (Kheradmand Kia et al., 2012; Shamseldin et al.,
2015). In this spectrum, the neurological problems predom-
inate in the clinical course, including severe cognitive,
motor and speech delay and only rarely seizures (17% of
total). The Rttn knockout mouse model (Faisst et al., 2002)
and the Nt natural rotatin mutant (Chatterjee et al., 2007)
are associated with embryonic heart looping defects and
failure to undergo axial rotation, the earliest events deter-
mining mammalian left-right asymmetry. In the human
RTTN case series, the malformations of internal organs
are less prominent and mostly not fatal. Review of all the
cases shows low but consistent frequency of internal organ
malformations, most frequently of the renal/urogenital
system (40%) within the MPD phenotype. The cause of
early death has been cerebral dysgenesis in three of four
cases (Shamseldin et al., 2015; Rump et al., 2016;
Wambach et al., 2018) and complications of congenital
heart disease in one of four (Shamseldin et al., 2015;
Rump et al., 2016; Wambach et al., 2018) (Table 1 and
Supplementary Table 2). The malformations of internal
organs are compatible with cilia abnormalities, i.e. SHH
pathway defects, but the relatively low frequency might
relate to the sufﬁcient residual rotatin protein function in
most individuals. Interesting is the occurrence of severe
dermatitis in few individuals (17%) reminiscent of skin
rashes in DNA repair disorders and Warsaw breakage syn-
drome (Bailey et al., 2015). Common survival into adult-
hood suggests lack of neurodegeneration, a typical
mechanism in MPD from DNA repair defects.
About 81% of the individuals are microcephalic at birth
and in total 86% (24 of 28 patients) have microcephaly at
follow-up, which means that lack of microcephaly at birth
is not an exclusion criterion for RTTN mutations (Table 1).
However, primordial dwarﬁsm, which can co-occur with
primary microcephaly, is not obligatory in all microceph-
alic subjects. The cortical malformations can be ascribed to
proliferation (simpliﬁed gyri), migration (lissencephaly, het-
erotopia) and organization (polymicrogyria-like dysgyria)
defects of the cortex, with predominance for underdevelop-
ment of the frontal telencephalon. The hindbrain is usually
spared. Abnormalities of the ventral telencephalon might
occur in some individuals with suspected mild frontal
lobar holoprosencephaly and fusion of basal ganglia
(Supplementary Table 2, P3) (Shamseldin et al., 2015;
Cavallin et al., 2018), hypoplastic olfactory bulb and ros-
trum of the corpus callosum, hypotelorism and eye mal-
development. Remarkably, many severely affected subjects
show large interhemispheric cysts (Grandone et al., 2016)
(Family I and Fig. 1O and P), sometimes with severe brain
disruption, a phenomenon that might relate to the hydro-
cephaly of Rttn/ knockout mice (Faisst et al., 2002).
Genotype–phenotype correlation
Review of all reported mutations shows that the variants
are not restricted to speciﬁc areas or putative rotatin func-
tional domains and they do not cluster with phenotypes
(Fig. 1Q and Supplementary Table 2). The recurrent homo-
zygous variant c.2953A4G has now been reported in three
unrelated families (Families C, D and H) from Morocco,
presenting with MPD and severe intellectual disability in
all, suggesting that it is a founder mutation in the
Moroccan population. However, no haplotype analysis
has been reported in support. Four (deep) intronic muta-
tions have an important phenotypic effect (Fig. 1Q), indi-
cating that diagnostic tests should include these four along
with careful analysis of RTTN non-coding regions. Indeed,
homozygous intronic splicing variants in RTTN (premature
stop) led to primary microcephaly and primordial dwarﬁsm
with a less severe outcome, a prolonged survival with a
stable non-progressive course, no epilepsy and no pre-
natal/infant lethality (c.[2885þ8A4G] and c.[2309þ
1093G4A], n = 2 families), likely due to the expression
of residual wild-type transcript (Fig. 2A) (Family B and
Shamseldin et al., 2015). However, a compound heterozy-
gous mutation with an intronic mutation in one allele and
an exonic missense in the other, led to refractory epilepsy
and dead in infant stage (c.32–3C4T) (Wambach et al.,
2018) and the combination of an intronic mutation with a
premature stop in an exon (c.[3705C4A];[4748–19T4A]
(Family I in Supplementary Table 2) even led to terminated
pregnancies with intrauterine growth restriction, micro-
cephaly, insufﬁcient cerebral sulcation, large posterior inter-
hemispheric cyst and cerebral schizencephalic clefts. Hence,
in case only one exonic RTTN mutation is detected and the
patient phenotype is as severe as described in these latter
cases, the presence of a (deep) intronic mutation in the
other allele should be considered. Moreover, when a
stable non-progressive course of the MPD phenotype is
observed, a homozygous intronic RTTN mutation should
be considered. Three of the four depicted intronic muta-
tions were picked up with whole exome sequencing, but
the deep intronic mutation c.[2309þ1093G4A] is only de-
tectable with whole genome sequencing (WGS). Therefore,
an alternative to WGS, this deep intronic variant should be
screened separately.
Interestingly, even the same homozygous RTTN muta-
tion can lead to a variable phenotype, e.g. P3 (Family C)
does not exhibit skin, cardiac and genital abnormalities, as
was described for two siblings with the same c.2953A4G
homozygous variant (P4, Family D) (Grandone et al., 2016;
Cavallin et al., 2018). Moreover, P3 (Family C) also has
suspected holoprosencephaly, which was not present in
Family D. Quantiﬁcation of RTTN mRNA with qPCR
shows residual transcripts in all affected individuals, includ-
ing those who died prematurely, suggesting that complete
lack of RTTN mRNA is probably embryonically lethal in
human, as seen in Rttn/ knockout mice (Faisst et al.,
2002). A clear genotype–phenotype correlation is lacking
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for the known RTTN mutations. One possible explanation
is that this large protein (2226 amino acids) has many pro-
tein interaction domains and interacts differently during the
phases of the cell cycle. So, the individual genetic make-up
could be an important determinant of the phenotype.
However, a link could be made between the amount of
RTTN wild-type mRNA expression and phenotypic sever-
ity. Three individuals in our cohort displayed a signiﬁcant
lower mRNA expression (Fig. 2A, P1–P3). Two of them,
grouped among the most severely affected individuals (P1
and P3), expressed only the transcript originating from the
missense allele (P1) or a combination of alternatively
spliced transcript with wild-type mRNA (P3) (Fig. 2A and
Supplementary Fig. 1A and C). Instead, P2, with a milder
phenotype, had a reasonable expression of wild-type se-
quence (Fig. 2A).
Dynamics of rotatin function in the
cell
To understand the phenotypic heterogeneity, we studied
RTTN mutant ﬁbroblasts to address the role of rotatin in
different pathways of cortical development (cell prolifer-
ation, ciliogenesis and neuronal migration).
To date, almost all known MCPH-associated genes play
a key role in centriole, centrosome and cell division regu-
lation. Rotatin has been previously localized to the centro-
some in HeLa, KE37 and U2OS (Stevens et al., 2009;
Kheradmand Kia et al., 2012; Chen et al., 2017), and we
conﬁrmed this localization in human ﬁbroblasts and human
iPSC-derived neurons. Interestingly, in RTTN mutated
ﬁbroblasts the residual protein does not localize to the
centrosome during mitosis but is spread rather diffusely
over the cytoplasm. The absence of rotatin in centrosomes
leads to centrosome ampliﬁcation during mitosis in all cell
lines bearing the mutations and siRTTN treated cell lines.
A similar observation has been made for D. melanogaster
homologue Ana3 mutant neuroblasts, showing 44% of cells
with centrosome ampliﬁcation, and RTTN//TP53/
knockout in RPE1 cells, showing numerous primitive
procentriole bodies (Stevens et al., 2010; Chen et al.,
2017). Variants in centrosome genes leading to super-
numerary centrosomes have also been described in individ-
uals with autosomal primary microcephaly and primordial
dwarﬁsm, caused by variants in STIL (Arquint and Nigg,
2014; Marthiens and Basto, 2014), CEP135 (Hussain
et al., 2012), CDK5RAP2 (Barrera et al., 2010), MCHP1
(Gambarotto and Basto, 2016) and CDK6 (Gambarotto
and Basto, 2016). Centrosome ampliﬁcation in RTTN mu-
tants thus seems to be a key factor in the aetiology of
MCPH. Although no exact correlation could be made be-
tween the percentage of centrosome ampliﬁcation and
phenotypic severity, siRTTN showed a lower ampliﬁcation
percentage (7%) than RTTN mutants (10–14%), suggest-
ing that residual wild-type rotatin contributed to normal
centrosome duplication. Moreover, patients with the same
RTTN mutation (P3 and P4, P7 and P8) displayed the
same percentages of centrosome ampliﬁcation.
We questioned the consequences of the observed centro-
some ampliﬁcation and how this could lead to depletion of
the neural progenitor pool during brain development.
Centrosome ampliﬁcation in murine neuronal stem cells is
known to highly reduce brain size at birth, through multi-
polar cell division and formation of merotelic kinetochore
attachments hindering timely chromatids segregation, even-
tually promoting aneuploidy (Marthiens et al., 2013).
Aneuploid neuronal stem cells can either enter apoptosis
or prematurely differentiate to neurons, overall depleting
the neuronal stem cell population at the ependymal ven-
tricular zone (Marthiens et al., 2013). Live imaging of
mitoses in RTTN mutated ﬁbroblasts uncovered that
centrosome ampliﬁcation induced multipolar cell divisions.
When studying cell cycle distribution in RTTN mutants
more extensively with ﬂow cytometry, we observed signiﬁ-
cant increase in aneuploid cells (44N) and consequent in-
crease in DNA fragmentation (sub-G1 fraction), indicating
apoptotic cell death. RTTN mutation also resulted in fewer
cells entering G1-phase, G2/M cell cycle arrest and a pro-
longed cell cycle. At this point, the process leading to the
observed centrosome ampliﬁcation due to RTTN mutation
is unclear. It is known that centrosome ampliﬁcation can
either result from a DNA damage induced G2/M phase
arrest, which is observed when DNA damage response
genes are implicated (MCPH1, and Seckel syndrome asso-
ciated ATR/ATM), or it can result directly from a defect in
cell division (tetraploidization) or in centrosome duplication
(Kra¨mer, 2009; Megraw et al., 2011; Godinho and
Pellman, 2014; Gambarotto and Basto, 2016). In analogy
with D. melanogaster homologue Ana3 mutant neuro-
blasts, centrosome ampliﬁcation in RTTN mutants might
be caused by centrosome missegregation due to failure in
pericentriolar matrix recruitment (Stevens et al., 2009).
Indeed, rotatin has been shown to be involved in recruit-
ment to the centrosome of CEP295 (Ana1 in D. melanoga-
ster), necessary for stabilization of the centrioles to become
competent for duplication (Chen et al., 2017). Whether the
observed G2/M phase arrest in RTTN mutants is the cause
rather than the consequence of the observed centrosome
ampliﬁcation and cell death remains to be elucidated. It
would be interesting to study the role of RTTN in DNA
damage response, especially since some clinical features are
similar to Seckel syndrome, and proteomics results of en-
dogenous rotatin showed high interaction with key regula-
tors in DNA damage response, e.g. CNOT1 (CCR4-NOT
transcription complex subunit 1), downstream ATM/ATR-
pathway proteins PSME3 and SIRT1 inhibitor CCAR2/
DBC1, E3 SUMO-protein ligase RANBP2 and E3 ubiqui-
tin-protein ligase HERC2. Overall, our study of cell cycle
suggests that microcephaly in RTTN mutants is caused by
both a defective mitosis and unscheduled apoptosis of neur-
onal progenitors during brain development, explaining why
the phenotype in some affected individuals worsened
postnatally.
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Rotatin has been previously implicated in ciliogenesis and
localized to the basal body of the primary cilium (Stevens
et al., 2009; Kheradmand Kia et al., 2012; Wambach et al.,
2018). Primary cilia of cerebral cortical progenitors and
neurons are paramount during multiple steps of corticogen-
esis, e.g. neurogenesis, apical-basal polarity of radial glial
scaffold, neuronal migration, development and connectivity
(Guo et al., 2015; De Mori et al., 2017). We show here
that six of the eight RTTN mutant ﬁbroblast cell lines had
a decreased number of ciliated cells and ﬁve of them had an
increased number of short cilia. 3D-SIM microscopy loca-
lized rotatin not only to the basal body but also to the
whole axoneme. We observed a defective stimulation of
the SHH pathway in some, but not all RTTN mutants,
potentially explaining phenotypic characteristics of the af-
fected individuals related to SHH defect [P1 had tetralogy
of Fallot, P3 and one individual from Shamseldin et al.
(2015) have suspected holoprosencephaly and 465% pre-
sent with midline defects]. Again, no exact correlation
could be made between the structural/functional integrity
of the primary cilia and the phenotype, but P1 and P3
ﬁbroblasts showed clear defective SHH stimulation
(Supplementary Fig. 5) and displayed among other patient
cells a lower amount of normal ciliated cells, potentially
correlating to the observed midline defects. These ﬁndings
highlight the role of rotatin in ciliogenesis.
The involvement of rotatin in centriole elongation (Chen
et al., 2017), centrosome ampliﬁcation and its localization
to the axoneme, conﬁrm the existence of interconnectivity
between ciliogenesis and cell cycle progression (Izawa et al.,
2015). Mass spectrometry of interacting partners uncover
that rotatin binds with the non-muscle cellular heavy chain
myosin complex (Supplementary Tables 4, 5 and
Supplementary Fig. 7). In animal models, other microceph-
aly associated proteins have been shown to interact with
this complex, Drosophila Asp (ASPM homologue) interacts
with Myo-II (MYH10 homologue) (Rujano et al., 2013).
Variants in neuronal isoform MYH10 have been described
in human and mice, leading to a RTTN-like phenotype
with microcephaly, short stature, disorders of neuronal mi-
gration, eye and cardiac defects (observed by G.M.S.M.,
and Ma et al., 2010; Tuzovic et al., 2013; Ma and
Adelstein, 2014). MYH10 is located in the vicinity of the
centrioles and knockdown of MYH10 in RPE1 cells leads
to impairment of ciliogenesis, similar to what we describe
for RTTN (Kheradmand Kia et al., 2012; Hong et al.,
2015). Moreover, double knockdown of Myh9 and
Myh10 in mice cardiac myocytes also showed centrosome
ampliﬁcation, multipolar mitotic spindle formation and
increased apoptosis (Ma et al., 2010). Next to a role in
cell cycle, centrosome ampliﬁcation and ciliogenesis,
MYH10 is a key component of neuronal migration, regu-
lating nucleokinesis (Juanes-Garcia et al., 2015). Variants
in Myh10, but also in Aspm, lead to mislocalization of
MYH10, impairment of cell polarity and delayed
nucleokinesis (Ma et al., 2004; Rujano et al., 2013).
MYH10 localizes to the leading edge of migrating neurons,
determining front–back polarization, increases actomyosin
bundling in the proximal end of the leading process, and
promotes somal translocation during nucleokinesis (Solecki
et al., 2009; Juanes-Garcia et al., 2015). We localized rota-
tin to the leading edge of migrating human iPSC-derived
neurons, together with MYH10 and -tubulin. Based on
the mass spectrometry results, co-localization in migrating
neurons and the known function of myosin-10 in neuronal
migration, we hypothesize that one of the processes leading
to neuronal migration defects in RTTN mutation could be
impairment of the rotatin-myosin binding.
Co-localization of rotatin with key regulators of neuronal
migration at the centrosome in the leading edge of migrat-
ing neurons, together with transient binding with myosin
isoforms, centrosomal proteins and microtubules, under-
lines the pivotal role of rotatin in neuronal migration.
Further extensive investigation in conditional animal
models of neuronal migration is required to prove this
hypothesis.
STIL, CEP135 and PPP1R35 have been proposed as
interacting proteins of rotatin (Gupta et al., 2015; Chen
et al., 2017; Sydor et al., 2018). Our mass spectrometry
results did not show binding of full-length exogenous or
endogenous rotatin with STIL, CEP135 or PPP1R35, pos-
sibly explained by the transience of some interactions
through the dynamic localization of rotatin during cell
cycle, or the speciﬁc RTTN constructs used. Chen et al.
(2017) showed that the truncated N-terminal of exogenous
rotatin (amino acids 1–889) binds with the N-terminal of
exogenous STIL, and that a defective binding with this
protein could explain the microcephalic phenotype in one
of the four studied RTTN variants (Chen et al., 2017).
However, not all RTTN cases, in this cohort and published
elsewhere, bear variants in this N-terminal domain, indicat-
ing that STIL is not the only mediator of rotatin function.
In conclusion, RTTN mutations lead to a complex and
heterogeneous human disease phenotype. We show that
rotatin is a dynamic protein involved in cell cycle progres-
sion and mitosis, in ciliogenesis and in neuronal migration,
providing clues to explain the different phenotypes and
conﬁrming its central role within the dynamic network of
centrosomal proteins (Jakobsen et al., 2011).
Web resources
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